Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications

Cardiovascular Revascularization Medicine : Including Molecular Interventions
Leonardo C ClavijoRon Waksman

Abstract

Metabolic syndrome (MS), the combination of hypertension, obesity, dyslipidemia, and insulin resistance, is a precursor of diabetes mellitus (DM) and highly prevalent among patients with acute myocardial infarction (AMI). Diabetes mellitus is associated with larger infarct size and worse outcomes after AMI. This study examined infarct size and short-term outcomes among nondiabetic patients with MS following contemporary treatment of AMI. Four hundred five consecutive patients with AMI treated with primary percutaneous coronary intervention were evaluated. Patients with diabetes (n=105) were excluded. Those with MS (n=167) included patients with three or more of the following criteria: hypertension, elevated fasting blood glucose, hypertriglyceridemia, low high-density lipoprotein, and obesity [body mass index (BMI)> or =30]. The control group (n=133) included patients without MS or DM. Baseline characteristics were similar except for hypertension, BMI, and dyslipidemia, which by study design were higher in the MS group. The MS group had larger infarct size as determined by peak creatine kinase-MB (79.8+/-133.8 vs. 30.84+/-51.5, P<.001). Overall in-hospital complications were higher in patients with MS (21.1% vs. 9.2%, P=.003). ...Continue Reading

References

Jul 15, 1995·BMJ : British Medical Journal·M E LeanC E Morrison
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Nov 26, 2002·Journal of the American College of Cardiology·Nazneem N WahabUNKNOWN ICONS Investigators
Dec 4, 2002·JAMA : the Journal of the American Medical Association·Hanna-Maaria LakkaJukka T Salonen
Sep 25, 2004·American Heart Journal·Jorik R TimmerUNKNOWN Zwolle Myocardial Infarction Study Group
Sep 29, 2004·Diabetes Care·Earl S FordAli H Mokdad
Apr 6, 2005·Journal of the American College of Cardiology·Jorik R TimmerUNKNOWN Zwolle Myocardial Infarction Study Group
May 25, 2005·Archives of Internal Medicine·Marianne ZellerUNKNOWN Observatoire des Infarctus de Côte-d'Or Survey Working Group
Jul 19, 2005·Journal of the American College of Cardiology·Giacomo LevantesiUNKNOWN GISSI-Prevenzione Investigators

❮ Previous
Next ❯

Citations

Sep 11, 2007·Diabetes, Obesity & Metabolism·D J Hausenloy, D M Yellon
Aug 8, 2012·Circulation·Andreas J FlammerAmir Lerman
Nov 20, 2012·Disease Models & Mechanisms·Daniel DonnerEugene F du Toit
Nov 16, 2013·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Sebastiano SciarrettaJunichi Sadoshima
Jan 22, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Janice V HuangGregory G Schwartz
May 1, 2010·Scandinavian Journal of Clinical and Laboratory Investigation·Ellen BøhmerSigrun Halvorsen
Jun 27, 2015·Clinical and Experimental Hypertension : CHE·Guan-Qi FanZhi-Hao Wang
Nov 1, 2012·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Z Yang, X-F Ming
Nov 9, 2010·The Journal of Clinical Hypertension·Jassim Al SuwaidiAhmed Al-Mottareb
Apr 3, 2010·Journal of the American College of Cardiology·Joshua M StolkerMikhail Kosiborod
Sep 13, 2012·Biochimica Et Biophysica Acta·Christophe Montessuit, René Lerch
Dec 22, 2009·Journal of Vascular Surgery·Mark G DaviesAlan B Lumsden
Nov 11, 2008·Biochimica Et Biophysica Acta·Annadora J Bruce-KellerChristopher D Morrison
Mar 20, 2015·Research in Cardiovascular Medicine·Shokoufeh HajsadeghiMaryam Mohsenian
Jul 19, 2016·Journal of Cellular Biochemistry·Christelle Viglino, Christophe Montessuit
May 18, 2017·Journal of Cellular Biochemistry·Christelle ViglinoChristophe Montessuit
Jun 16, 2012·Vascular·Daynene Vykoukal, Mark G Davies
Feb 2, 2008·Stroke; a Journal of Cerebral Circulation·Satoshi TeraoD Neil Granger
Jul 28, 2007·Journal of the American Society of Nephrology : JASN·Ravindra L Mehta
Jun 4, 2019·Pflügers Archiv : European journal of physiology·Christelle ViglinoChristophe Montessuit
May 21, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Allen M AndresRobert M Mentzer
Sep 16, 2010·Journal of Cardiopulmonary Rehabilitation and Prevention·Melissa D ZulloLeila W Jackson
Nov 10, 2020·Nutritional Neuroscience·Oluwatomilayo Patience OjoGloria Patricia Cardona-Gómez
Dec 19, 2020·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Xiaoli YangDanhong Wu
Apr 8, 2016·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·I PapageorgiouC Montessuit

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.